Role of protein–protein interactions in the antiapoptotic function of EWS-Fli-1
- 26 July 2004
- journal article
- Published by Springer Nature in Oncogene
- Vol. 23 (42) , 7087-7094
- https://doi.org/10.1038/sj.onc.1207927
Abstract
In the majority of Ewing's family tumors, chromosomal translocation t(11;22) leads to aberrant fusion of RNA-binding protein EWS with DNA-binding ETS transcriptional factor Fli-1. EWS-Fli-1 has altered the transcriptional activity and modulating its downstream target genes through this transcriptional activity is thought to be responsible for this tumor. We have previously shown that both EWS-Fli-1 and Fli-1 have antiapoptotic activity against several apoptotic inducers. Here, we show that the transcriptional activity of EWS-Fli-1 and Fli-1 is not essential for its antiapoptotic activity. We also demonstrate that EWS-Fli-1 and Fli-1 interact with CBP through its amino-terminal region and inhibit the CBP-dependent transcriptional activity of RXR. This activity appears to be independent of DNA-binding activity of EWS-Fli-1. Introduction of the dominant-negative form of CBP into Ewing's sarcoma cells sensitizes these cells against genotoxic or retinoic-acid induced apoptosis. These results suggest that the ability of EWS-Fli-1/Fli-1 to target transcriptional cofactor(s) and modulate apoptotic pathways may be responsible for its antiapoptotic and tumorigenic activities.Keywords
This publication has 41 references indexed in Scilit:
- PIM3 Proto-Oncogene Kinase Is a Common Transcriptional Target of Divergent EWS/ETS OncoproteinsMolecular and Cellular Biology, 2003
- Inhibition of p300/CBP by Early B-Cell FactorMolecular and Cellular Biology, 2003
- Cooperative Interaction of EWS with CREB-binding Protein Selectively Activates Hepatocyte Nuclear Factor 4-mediated TranscriptionPublished by Elsevier ,2003
- Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16Cancer Gene Therapy, 2002
- Function for p300 and not CBP in the apoptotic response to DNA damageOncogene, 1999
- Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activityOncogene, 1999
- Fli-1b is generated by usage of differential splicing and alternative promoterOncogene, 1998
- Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase IIOncogene, 1998
- BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinasesOncogene, 1997
- A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear ReceptorsCell, 1996